Should we switch over to tolterodine in every child with non-neurogenic daytime urinary incontinence in whom oxybutynin failed?


YUCEL S., AKKAYA E., GUNTEKIN E., KUKUL E., DANISMAN A., Akman S., ...Daha Fazla

UROLOGY, cilt.65, sa.2, ss.369-373, 2005 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 65 Sayı: 2
  • Basım Tarihi: 2005
  • Doi Numarası: 10.1016/j.urology.2004.09.036
  • Dergi Adı: UROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.369-373
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Objectives. To assess the clinical efficacy of tolterodine prescribed to children with non-neurogenic daytime urinary incontinence secondary to overactive bladder who had previously failed to improve with oral oxybutynin treatment and its relation to the side-effect profile and compliance status.